Target intelligence / Profile preview

Calcium absorption promotion

Molecular classification
Other (the term encompasses multiple classes including transporters, channel proteins, and nuclear hormone receptors)
01

Overview

"Calcium absorption promotion" refers to a broad set of molecular and physiological pathways that increase the uptake of calcium from the intestine into systemic circulation. The most critical effectors in this process are the vitamin D receptor (VDR; a nuclear hormone receptor), calcium channels such as TRPV6 (formerly CaT1), calbindin-D9k, and plasma membrane calcium ATPase (PMCA1b), all working together to facilitate active transcellular transport of calcium in the duodenum and upper jejunum. Paracellular (passive) mechanisms, regulated by tight-junction proteins like claudin-2, claudin-12, and claudin-15, also contribute, especially when calcium intake is high[1][2][3][4]. Endocrine factors such as vitamin D (via VDR), parathyroid hormone (PTH), prolactin, and calcitonin orchestrate these cellular changes to meet varying calcium demands in health and disease[3][4][5][6]. Because this description encapsulates a physiological process involving multiple distinct molecules and pathways, "calcium absorption promotion" is not considered a standalone druggable molecular target but instead a therapeutic goal enabled by modulating specific underlying molecular targets.

Other names
Calcium uptake enhancementenhanced intestinal calcium absorptionpromoted calcium transportstimulation of calcium uptake
02

Mechanism of action

Stimulation of active intestinal calcium transport (via upregulation of CaT1/TRPV6 and calbindin by 1,25-dihydroxyvitamin D3); Modulation of paracellular calcium absorption (via tight junction proteins such as claudin-2, claudin-12, claudin-15); Upregulation of calcium absorption by hormone signaling (e.g., vitamin D receptor, prolactin receptor)

03

Biological functions

Intestinal calcium absorptionCalcium homeostasisBone mineralizationHormonal regulationSignal transduction
04

Disease associations

OsteoporosisRicketsHypocalcemiaHypercalcemiaRenal osteodystrophyOther disorders of calcium metabolism
05

Safety considerations

Hypercalcemia (risk with excessive stimulation)Hypocalcemia (risk if absorption is impaired)Renal calculi with calcium over-supplementationDysregulation contributing to osteomalacia/osteoporosis
06

Interacting drugs

Vitamin D analogs (e.g., calcitriol/cholecalciferol)

4 more in the full profile.

07

Biomarkers

Serum 1,25-dihydroxyvitamin D3 levelsExpression levels of intestinal TRPV6, calbindin, and claudinsSerum calciumParathyroid hormone (PTH) levels

Beyond the preview

Go deeper on Calcium absorption promotion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium absorption promotion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call